Subscribe
type here...
Subscribe

Tag: Investments

Amgen sells its Turkish manufacturing arm for $135M

Global Markets Pharma -
Amgen, which has been beefing up its U.S. manufacturing operations, sold its stake in Turkey’s oldest pharmaceutical company Gensenta...

Pfizer and BioNTech announce new $3.2 billion agreement to supply the COVID-19 vaccine to the US

Global Markets Pharma -
Pfizer Inc. and BioNTech SE announced today a new vaccine supply agreement with the U.S. government, according to which...

Fujifilm plans a $1.6 billion expansion at CDMO facilities in Denmark and Texas

Global Markets Pharma -
Fujifilm isn’t slowing down on its expansion roll. Just a few months after it bought Shanandoah Biotechnology for an...

Spero Therapeutics plummets 15% as FDA rejects new drug application

Global Markets Pharma -
Spero Therapeutics , Inc. shares plunged around 15% after-hours following the company’s announcement, according to which the U.S. Food...

Sutro Biopharma shares soar 67% due to cooperation with Astellas in cancer treatment

Global Markets Pharma -
Sutro Biopharma Inc. shares leaped 67% to $7.24 a share in U.S. after-hours trading after the South San Francisco...

Biotech investors focus on biotechs with drugs closer to market

Global Markets Pharma -
Biotech investors nursing losses from stock price falls are now focusing on firms which are closer to getting their...

Bristol Myers must face $6.4 bln lawsuit over delayed cancer drug

Global Markets Pharma -
A U.S. judge on Friday refused to dismiss a $6.4 billion lawsuit accusing Bristol Myers Squibb Co of delaying...

Gurnet Point Capital, Patient Square Capital agreed to pay up to $890 million for biotechnology

Global Markets Pharma -
Radius Health, a maker of bone and cancer drugs, has agreed to be taken private in an acquisition worth...

AVEO Oncology signs collaboration and supply agreement with Eli Lilly

Global Markets Pharma -
AVEO Oncology Inc. said it has entered into a clinical trial collaboration and supply agreement in North America with...

Novartis loses over $2.7 billion in patent appeal of multiple sclerosis drug

Global Markets Pharma -
A U.S. appeals court on Tuesday ruled that a patent related to Swiss drugmaker Novartis AG's blockbuster multiple sclerosis...

Alladapt announces $119M institutional financing to support ongoing clinical development

Global Markets Pharma -
Alladapt Immunotherapeutics Inc., a private, clinical-stage biopharmaceutical company developing prescription therapeutics to address IgE-mediated food allergy, announced today the...

ResApp stock returned from trading halt, down 29%

Global Markets Pharma -
The ResApp Health Ltd share price has returned from its trading halt and taken a tumble. In morning trade,...

PHARMPROM is a premier digital resource for the pharmaceutical sector, combining breaking news, deep insights, and key market events. We cover the entire product lifecycle—from R&D and manufacturing to distribution—in strict accordance with Good Pharmaceutical Practices (GxP).

Disclaimer All content on pharmprom.net is for informational purposes only and does not constitute medical advice. The materials are intended exclusively for industry professionals and are not addressed to the general public.

Company

Headlines

Newsletter

Get important news delivered directly to your inbox and stay connected!

© PHARMPROM 2026